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Abstract
Background: The Family Blood Pressure Program is an ongoing, NHLBI-sponsored, multi-center program to study the genetic
determinants of high blood pressure. The goal of this particular study was to study patterns of metabolic syndrome (MetS) in
four ethnic groups: African Americans, Caucasians, Hispanics, and Asians.
Methods: A major part of participants in three networks GENOA, HyperGEN and SAPPHIRe were recruited mainly through
hypertensive probands. MetS was defined as a categorical trait following the National Cholesterol Education Program definition
(c-MetS). MetS was also characterized quantitatively through multivariate factor analyses (FA) of 10 risk variables (q-MetS).
Logistic regression and frequency tables were used for studying associations among traits.
Results: Using the NCEP definition, the Hispanic sample, which by design was enriched for type 2 diabetes (T2D), had a very
high prevalence of MetS (73%). In contrast, its prevalence in Chinese was the lowest (17%). In African Americans and Hispanics,
c-MetS was more prevalent in women than in men. Association of c-MetS with type 2 diabetes (T2D) was prominent in the
Hispanics and African Americans, less pronounced in the Whites and Japanese, (although still significant), and weakest in the
Chinese sample.
Using FA without rotation, we found that the main factor loaded obesity (OBS) and blood pressure (BP) in African Americans;
OBS and insulin (INS) in Hispanics, in Japanese, and in Whites; and OBS alone in Chinese. In Hispanics, Whites, and Japanese,
BP loaded as a separate factor. Lipids in combination with INS also loaded in a separate factor. Using FA with Varimax rotation,
4 independent factors were identified: "Obesity-INS," "Blood pressure," "Lipids-INS," and "Central obesity." They explained
about 60% of the variance present in the original risk variables.
Conclusion: MetS ethnic differences were identified. Ascertaining for hypertension or T2D increased the MetS prevalence in
networks compared with the one in the US general population. Obesity was the most prominent risk factor contributing to
both c-MetS and q-MetS. INS contributed in two important factors (obesity and lipids). The information imbedded into c-MetS
trait /q-MetS factors scores can contribute in future research of the MetS, especially its utilization in the genetic analysis.
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Metabolic syndrome (MetS) is defined as a clustering of
cardiovascular and type 2 diabetes risk factors including
obesity, insulin resistance, dyslipidemia, and hyperten-
sion (HT). The genetic control of MetS is expected to be
complex since it represents a syndrome of multifaceted
abnormalities. Categorical and clinically applicable crite-
ria were developed by the National Cholesterol Education
Program (NCEP), which defined MetS as the presence in
an individual of at least 3 out of 5 risk factors (increased
waist circumference (WAIST), increased level of triglycer-
ides (TG), low levels of high density lipoprotein choles-
terol (HDL), HT, and fasting glucose (GLUC) ≥ 110 mg/
dl) [1].
We designated this dichotomous definition of MetS (pres-
ence or absence) as c-MetS (see also Material and Meth-
ods). Quantitative factor analytic treatment of MetS was
designated as q-MetS (see Material and Methods). Several
earlier studies have employed multivariate techniques
such as factor analysis (FA) to investigate MetS. This
method transforms a set of MetS risk variables to a smaller
set of latent factors. Most studies have reported 2 to 4
underlying factors, depending on the number of risk fac-
tors included, whether or not the Varimax rotation was
used, and statistical decisions made [2-7].
This study is an investigation of MetS in the Family Blood
Pressure Program (FBPP) [8]. The FBPP is comprised of 4
different networks: GenNet, GENOA, HyperGEN, and
SAPPHIRe. These networks were established to study the
genetic determinants of high blood pressure.
The goal of this particular study was to evaluate MetS in
the rich FBPP database using both the c-MetS and q-MetS
definitions. Common features and differences among the
major ethnic groups were explored. Finally, the relation-
ships of c-MetS with T2D and vascular heterogeneous
atherosclerotic (VHA) events were also investigated.
Materials and methods
Participants
The FBPP pooled database (version 3) of 13,592 partici-
pants from 4 different networks represents one of the larg-
est compilations of ethnically diverse data. GenNet had
only partial data for defining c-MetS and therefore, data
from GenNet were excluded from analysis. GENOA
(Genetic Epidemiology Network of Atherosclerosis)
includes 3 field centers: the Jackson, MS center recruited
African Americans; the one in Starr County, TX recruited
Hispanics; the one in Rochester, MN, recruited Whites.
HyperGEN (Hypertension Genetic Epidemiology Net-
work) included field centers in Birmingham AL, which
recruited African Americans; the rest of centers in Forsyth
County, NC, in Framingham, MA, in Minneapolis, MN,
and in Salt Lake City, UT recruited Whites. SAPPHIRe
(Stanford Asian Pacific Program in Hypertension and
Insulin Resistance), with 3 major field centers, recruited
Asian Pacific populations of Chinese origin residing in
Taiwan and of Japanese origin residing in Hawaii, and
California. GENOA recruited African American, Hispanic,
and White sibships with at least 2 hypertensive sibs (with
HT onset before the age of 60). The Hispanic sibships
were recruited with at least 2 sibs who were each diag-
nosed as type 2 diabetic (T2D). HyperGEN recruited Afri-
can American and White hypertensive sibships with 2 or
more hypertensive sibs, at least 1 of them having severe
HT. In addition, HyperGEN recruited random samples of
African American and White participants, and parents.
SAPPHIRe recruited sib-pairs concordant and/or discord-
ant for hypertension. For all participants the diet was
uncontrolled and reflective of the "free-living" dietary
habits of these populations.
We analyzed data from the FBPP where participants with
data for defining c-MetS included: 1857 African Ameri-
cans, 1799 Hispanics, and 1578 Whites in GENOA; 2010
African Americans, and 1888 Whites in HyperGEN; 1630
Chinese, and 581 Japanese participants in SAPPHIRe). In
all networks, subjects with unknown ethnicity were
excluded. As a result, information on a total of 11,343 par-
ticipants was considered in the c-MetS study (Tables 1, 2,
3). In contrast, the sample sizes for q-MetS were consider-
ably smaller because there were only 7,562 participants
with no missing values for any of the 10 risk factors (see
Material and Methods for risk factors analyzed and Table
5 for the exact sample sizes).
It is important to mention that each network had different
exclusion criteria when recruiting participants: GENOA
had excluded any case of HT secondary to other diagnoses
or HT onset after age 60; HyperGEN had excluded type I
diabetics, secondary hypertensives, or HT onset after age
60; SAPPHIRe had excluded participants with the follow-
ing conditions: if they were using insulin or other pre-
scription for diabetes, with cancer diagnosis, cirrhosis of
the liver, terminal illness, and body mass index (BMI) >
35 kg/m2.
Metabolic Syndrome, T2D and the VHA Definition
The categorical trait c-MetS was created employing the
NCEP definition. c-MetS was defined by the presence of 3
or more of the following abnormalities in an individual:
WAIST > 102 cm in men or > 88 cm in women, TG ≥ 150
mg/dl, HDL < 40 mg/dl in men or < 50 mg/dl in women,
systolic blood pressure (SBP) ≥ 130 mm Hg and/or diasto-
lic blood pressure (DBP) ≥ 85 mm Hg, or on treatment for
HT, and GLUC ≥ 110 mg/dl or on treatment for diabetes
[1]. The quantitative trait q-MetS was defined by the clus-
tering patterns of 10 risk factors. The following risk factorsPage 2 of 13
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African Americans (N = 1312) Hispanics (1160) Whites (1073)
Variables Mean St. Dev. Mean St. Dev. Mean St. Dev.
AGE 58 10 55 12 55 11
BMI 31 7 31 6 30 6
WAIST 103 17 107 14 99 16
WHR 0.91 0.08 0.97 0.08 0.91 0.09
INS 11 10 14 14 9 7
GLUC 108 42 142 64 98 26
LDL 121 40 116 35 122 34
HDL 57 18 47 13 54 16
TG 126 43 162 47 156 47
SBP 130 23 129 22 133 19
DBP 71 11 70 10 76 10
Table 2: Variables Analyzed in the FA (HyperGEN)
African Americans (1731) Whites (1255)
Variables Mean St. Dev. Mean St. Dev.
AGE 48 13 56 13
BMI 32 7 30 6
WAIST 102 17 103 15
WHR 0.90 0.08 0.94 0.08
INS 11 9 8 6
GLUC 109 45 103 30
LDL 120 37 118 32
HDL 54 15 49 15
TG 104 56 152 75
SBP 130 22 123 20
DBP 75 12 69 11
Table 3: Variables Analyzed in the FA (SAPPHIRe)
Chinese (747) Japanese (284)
Variables Mean St. Dev. Mean St. Dev.
AGE 50 9 55 9
BMI 25 3 27 4
WAIST 84 11 90 12
WHR 0.87 0.08 0.91 0.09
INS 8 5 8 5
GLUC 92 18 101 21
LDL 124 37 121 34
HDL 43 12 48 14
TG 124 69 166 78
SBP 132 25 136 21
DBP 78 14 79 11Page 3 of 13
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GENOA N = 1160 Hispanics
N = 1312 BMI WAIST WHR INS GLUC LDL HDL TG SBP DBP
A. BMI - 0.84‡ 0.33‡ 0.40‡ -0.15‡ -0.03 -0.17‡ 0.12‡ 0.16‡ 0.03
A WAIST 0.87‡ - 0.63‡ 0.37‡ -0.19‡ -0.03 -0.18‡ 0.12‡ 0.19‡ 0.06*
m WHR 0.38‡ 0.68‡ - 0.24‡ -0.21‡ 0.03 -0.16‡ 0.13‡ 0.18‡ 0.10‡
e INS 0.45‡ 0.45‡ 0.31‡ - -0.13‡ -0.08† -0.18‡ 0.19‡ 0.10 0.03
r GLUC †† -0.28‡ -0.30‡ -0.26‡ -0.38‡ - -0.03 0.15‡ -0.18‡ -0.17‡ -0.10‡
I LDL 0.03 0.04 0.05 0.05 -0.03 - 0.01 0.19‡ 0.04 0.07*
c HDL -0.18‡ -0.21‡ -0.20‡ -0.33‡ 0.18‡ -0.12 - -0.30‡ 0.01 0.05
a TG 0.13‡ 0.19‡ 0.21‡ 0.30‡ -0.20‡ 0.20‡ -0.34‡ - 0.14‡ 0.09†
n SBP 0.13‡ 0.14‡ 0.14‡ 0.08† -0.12‡ 0.04 0.00 0.06* - 0.72‡
s DBP -0.02 0.00 0.06* -0.01 -0.02 0.06* 0.03 0.04 0.75‡ -
GENOA
N = 1073 BMI WAIST WHR INS GLUC LDL HDL TG SBP DBP
BMI -
WAIST 0.90‡ -
WHR 0.51‡ 0.74‡ -
INS 0.57‡ 0.57‡ 0.42‡ -
W GLUC -0.32‡ -0.31‡ -0.24‡ -0.41‡ -
h LDL 0.00 0.02 0.01 0.00 -0.02 -
i HDL -0.28‡ -0.30‡ -0.27‡ -0.37‡ 0.18‡ -0.12 -
t TG 0.28‡ 0.29‡ 0.21‡ 0.31‡ -0.17‡ 0.16‡ -0.37‡ -
e SBP 0.24‡ 0.22‡ 0.14‡ 0.16‡ -0.15‡ 0.00 -0.04 0.12‡ -
s DBP 0.07* 0.09† 0.09† 0.03 -0.02 0.05 0.02 0.12‡ 0.68‡ -
HyperGEN N = 1255 Whites
N = 1731 BMI WAIST WHR INS GLUC LDL HDL TG SBP DBP
A. BMI - 0.89‡ 0.45‡ 0.51‡ -0.31‡ 0.04 -0.19‡ 0.22‡ 0.17‡ 0.01
A WAIST 0.90‡ - 0.68‡ 0.50‡ -0.32‡ 0.06* -0.19‡ 0.24‡ 0.13‡ 0.00
m WHR 0.45‡ 0.70‡ - 0.35‡ -0.24‡ 0.06* -0.21‡ 0.25‡ 0.12‡ 0.07*
e INS 0.49‡ 0.51‡ 0.43‡ - -0.30‡ -0.03 -0.35‡ 0.35‡ 0.17‡ 0.07*
r GLUC -0.27‡ -0.30‡ -0.29‡ -0.40‡ - -0.05 0.19‡ -0.21‡ -0.13‡ -0.02
I LDL 0.12‡ 0.11‡ 0.09‡ 0.09‡ -0.08 - -0.01 0.08† 0.05 0.06*
c HDL -0.21‡ -0.24‡ -0.27‡ -0.37‡ 0.24‡ -0.15‡ - -0.43‡ -0.01 0.05
a TG 0.18‡ 0.23‡ 0.29‡ 0.36‡ -0.29‡ 0.18‡ -0.41‡ - 0.11‡ 0.04
n SBP 0.18‡ 0.16‡ 0.11‡ 0.05 -0.06 0.02 0.04 0.04 - 0.68‡
s DBP -0.03 -0.03 0.01 -0.06* 0.05* 0.00 0.07† -0.02 0.74‡ -
SAPPHIRe N = 284 Japanese
N = 747 BMI WAIST WHR INS GLUC LDL HDL TG SBP DBP
BMI - 0.83‡ 0.31‡ 0.64‡ -0.33‡ 0.15* -0.29‡ 0.22‡ 0.18‡ 0.03
WAIST 0.78‡ - 0.62‡ 0.58‡ -0.28‡ 0.17† -0.24‡ 0.20‡ 0.09 -0.02
WHR 0.38‡ 0.73‡ - 0.30‡ -0.14 0.08 -0.13* 0.19‡ 0.06 0.02
C INS 0.54‡ 0.51‡ 0.31‡ - -0.41‡ 0.11 -0.37‡ 0.32‡ 0.19‡ 0.09
h GLUC -0.24‡ -0.23‡ -0.15‡ -0.41‡ - -0.07 0.35‡ -0.18† -0.10 0.03
i LDL 0.03 0.02 -0.03 0.01 0.05 - -0.10 0.08 0.09 0.10
n HDL -0.23‡ -0.23‡ -0.16‡ -0.31‡ 0.14‡ 0.02 - -0.41‡ -0.15* -0.09
e TG 0.33‡ 0.30‡ 0.25‡ 0.40‡ -0.25‡ 0.01 -0.37‡ - 0.21‡ 0.12*
s SBP 0.20‡ 0.20‡ 0.16‡ 0.07 -0.04 0.01 -0.01 0.13‡ - 0.69‡
e DBP 0.17‡ 0.17‡ 0.12‡ 0.08* -0.02 0.02 -0.02 0.14‡ 0.84‡ -
* p < 0.05; † p < 0.01 ; ‡ p < 0.001 ; †† A negative correlation of GLUC and INS is result of the inverse squared transformation of GLUCPage 4 of 13
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hip ratio (WHR), fasting insulin (INS, µU/ml), fasting
GLUC (mg/dl), SBP and DBP, mm Hg), low density lipo-
protein cholesterol (LDL, mg/dl), HDL (mg/dl) and fast-
ing triglycerides (TG, mg/dl). To maintain consistency
among the three networks, the minimum fasting time
required was set at 8 hours.
Type 2 diabetes was defined by a fasting GLUC ≥ 126 mg/
dl, or current use of hypoglycemic medication or insulin
that was documented at examination in the clinic, or dia-
betes reported on questionnaires. An age of onset ≥ 40
years was also required to diagnose T2D [9].
In the FBPP pooled database, three important VHA varia-
bles were available from questionnaires: stroke or tran-
sient ischemic attacks, heart attack, and bypass or
angioplasty. If any of these were reported in an individual,
it was used to define the VHA status.
Statistical analysis
The 10 risk variables of MetS were checked for normality
and outliers. Each variable was adjusted for age, age2, age3,
and field center within each gender-by-race-by-Network
group. INS, TG, and HDL were transformed by natural
logarithm to render them approximately normal. Like-
wise, GLUC was transformed as the inverse of the squared
value (1/GLUC2). These transformations, together with
standardization to zero mean and unit variance, prepared
the data for FA. FA was performed by employing the FAC-
TANAL function in S-plus version 6.1, Insightful Corp.,
Seattle. We applied an exploratory factor analysis where
the extraction of the latent factors was performed based
on the maximum likelihood estimation [10]. The statisti-
cal details of FA may be found elsewhere [11,12]. In short,
FA explains the relationships among the risk variables in
terms of a fewer number of underlying latent factors. The
data were analyzed with and without Varimax rotation.
When no rotation is applied, the first few factors can be
considered the most important for MetS. Kaiser (1958)
proposed the Varimax rotation that maximizes the sum of
variances (of squares of loadings) for latent factors [13].
The two options provide ways of identifying the structure
of the latent factors for MetS. One may consider "No rota-
tion" for understanding how risk factors cluster to repre-
sent MetS; Varimax rotation may be used to identify
distinct latent factors. This can be useful in genetic analy-
ses [14]. Factor loadings are correlation coefficients
between the original risk variables and the latent factors
[12]. A loading ≥ 0.4 is interpreted as representing an
important contribution of an original variable to the
latent factor (marked in bold in Tables 6 and 7).
Odds ratios, prevalence rates, and their confidence inter-
vals were estimated by utilizing the FREQ and LOGISTIC
regression procedures of SAS. Means and standard devia-
tions were estimated with SAS software v. 9.0., SAS Insti-
tute, NC [15].
Results
Mean age of participants ranged from 48 years in the
HyperGEN African Americans to 58 years in the GENOA
African Americans (Tables 1, 2, 3). Mean BMI and WAIST
were higher for African Americans, Hispanics, and Whites
than for Japanese and Chinese. A mean of approximately
130 mm Hg with a standard deviation of 20 mm Hg was
evident for SBP across the networks and ethnicities.
c-MetS
Among African Americans, twice as many were hypertrig-
lyceridemic in GENOA than in HyperGEN, even though
they were very comparable for all other MetS risk factors.
This difference contributed to a relatively higher
percentage of c-MetS in GENOA African Americans (41%)
than in HyperGEN African Americans (34%). Whites in
both networks were similar with respect to all NCEP
thresholds (Figure 1).
The percentages of participants beyond the NCEP thresh-
olds differed by ethnicity. The percentage of Japanese
above the NCEP threshold for WAIST was half that of His-
panics, African Americans, or Whites, but twice that of the
Chinese. The percentage of Japanese participants above
the NCEP threshold for TG was similar to that in Whites,
but about twice as large as in the Chinese; twice as many
Whites were above the TG threshold than African Ameri-
cans. The percentage of Japanese above the GLUC
threshold, or on hypoglycemic medications, was similar
to that in Whites, but about 3 times lower than in Hispan-
ics and about 3 times higher than in the Chinese sample.
The primary risk factors for c-MetS were WAIST, HDL, and
blood pressure (BP) in African Americans, Hispanics, and
Whites; TG had smaller weight in African Americans, but
higher in Hispanics and Whites; in the Japanese, TG, HDL,
BP, and to a smaller degree WAIST; and in the Chinese,
HDL, BP, and less of TG. Hispanics also had a higher con-
tribution of GLUC. Hispanics had a total of 73% of partic-
ipants with at least 3 risk factors beyond the thresholds
(MS3: 24%; MS4: 30%; MS5: 19%). Levels lower than the
NCEP thresholds were more frequent in the Chinese and
in the Japanese samples than in Hispanics, African Amer-
icans, or Whites. As expected, all networks and ethnicities
selected had a high percentage of participants above the
NCEP threshold for SBP/DBP or using hypertensive med-
ications. For a better comparison, similar ethnicities were
combined across networks (Figure 1).
Performing logistic regression on c-MetS risk factors, by
using dummy variables defined as 1 if a risk factor was
equal or beyond the NCEP thresholds, 0 otherwise,Page 5 of 13
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of the 5 NCEP MetS risk factors (Results not shown).
Looking at the q-MetS patterns, Asians had more a contri-
bution of hypertension and dyslipidemia. Whites and
African Americans showed a classical MetS as a combina-
tion of obesity, dyslipidemia, and hypertension, much
like the Hispanics (Figure 1).
c-MetS and T2D
The presence of c-MetS was associated with T2D. This
association was highly expressed in the Hispanics, where
c-MetS and T2D were present simultaneously in 57% of
the sample. The lowest percentage of participants with
both c-MetS and T2D was 2% in the Chinese (Figure 2).
All the association tests between c-MetS and T2D were
Table 6: Loadings of the Original Risk Factors in the Latent Factors by Network, Ethnicity (No Rotation)
Rotation 
"NONE" 
Network/ 
Ethnicity
Factor BMI WAIST WHR INS GLUC LDL HDL TG SBP DBP SS loadings
GENOA 
(African 
Americans)
Factor 1 0.75 † 0.68 0.34 0.36 -0.26 -0.12 0.12 0.75 0.48 2.17
Factor 2 0.66 0.55 0.18 0.28 -0.12 -0.14 -0.66 -0.58 1.66
Factor 3 0.38 0.92 0.15 -0.16 -0.15 0.17 1.10
Factor 4 0.45 -0.32 0.20 -0.50 0.52 0.87
GENOA 
(Hispanics)
Factor 1 1.00 0.84 0.33 0.40 -0.15 -0.17 0.13 0.16 2.07
Factor 2 0.16 0.37 -0.21 0.28 0.89 0.72 1.61
Factor 3 0.35 0.76 0.13 -0.13 -0.20 0.23 -0.29 -0.25 0.98
Factor 4 -0.13 -0.22 0.11 0.18 -0.27 0.85 0.92
GENOA 
(Whites)
Factor 1 1.00 0.92 0.57 0.59 -0.33 -0.30 0.28 0.19 2.81
Factor 2 0.12 0.68 1.00 1.50
Factor 3 0.35 -0.25 0.19 -0.53 0.47 0.73
Factor 4 0.27 0.75 0.12 -0.16 0.70
HyperGEN 
(African 
Americans)
Factor 1 0.77 0.69 0.37 0.35 -0.21 -0.11 0.15 0.77 0.46 2.21
Factor 2 0.64 0.58 0.27 0.35 -0.16 -0.20 0.11 -0.64 -0.60 1.80
Factor 3 0.36 0.80 0.28 -0.23 -0.25 0.30 1.05
Factor 4 0.39 -0.34 0.18 -0.51 0.54 0.87
HyperGEN 
(Whites)
Factor 1 0.96 0.97 0.61 0.53 -0.33 -0.21 0.25 0.17 2.75
Factor 2 0.11 0.84 0.80 1.37
Factor 3 0.37 -0.21 -0.65 0.56 0.92
Factor 4 -0.23 0.16 0.58 0.14 0.45
SAPPHIRe 
(Chinese)
Factor 1 0.38 0.73 1.00 0.32 -0.15 -0.17 0.25 0.16 0.12 1.93
Factor 2 0.53 0.39 0.30 -0.14 -0.11 0.23 0.77 0.78 1.82
Factor 3 0.61 0.48 0.44 -0.23 -0.21 0.18 -0.45 -0.47 1.36
Factor 4 0.11 -0.42 0.36 0.37 -0.49 0.70
SAPPHIRe 
(Japanese)
Factor 1 0.83 1.00 0.62 0.58 -0.28 0.17 -0.24 0.20 2.63
Factor 2 0.19 0.18 -0.14 0.15 0.70 0.96 1.54
Factor 3 0.10 0.34 -0.41 -0.60 0.50 0.12 0.93
Factor 4 -0.52 0.36 -0.24 0.18 0.11 0.27 0.59
†The loadings > = 0.40 are in bold. Page 6 of 13
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Nutrition & Metabolism 2005, 2:17 http://www.nutritionandmetabolism.com/content/2/1/17Table 7: Loadings of the Original Risk Factors in the Latent Factors by Network, Ethnicity (Varimax Rotation)
Rotation 
"Varimax"
GENOA
African Americans Whites Hispanics
Factors / 
Variables
Factor 1 Factor 2 Factor 3 Factor 4 Factor 1 Factor 2 Factor 3 Factor 4 Factor 1 Factor 2 Factor 3 Factor 4
BMI 0.99 † 0.02 0.14 0.07 0.97 0.11 0.14 0.12 0.99† 0.05 -0.01 0.04
WAIST 0.83 0.03 0.19 0.43 0.83 0.10 0.46 0.15 0.82 0.07 0.01 0.44
WHR 0.28 0.06 0.22 0.93 0.38 0.06 0.85 0.15 0.29 0.08 -0.11 0.88
INS 0.38 0.01 0.53 0.10 0.51 0.03 0.18 0.44 0.39 0.04 0.15 0.12
GLUC -0.21 -0.07 -0.38 -0.12 -0.28 -0.01 -0.09 -0.30 -0.14 -0.14 -0.18 -0.15
LDL 0.00 0.03 0.20 0.01 -0.03 0.04 -0.01 0.19 -0.03 0.04 0.20 0.01
HDL -0.10 0.05 -0.54 -0.06 -0.20 0.05 -0.12 -0.58 -0.17 0.06 -0.31 -0.10
TG 0.04 0.01 0.56 0.08 0.20 0.10 0.07 0.52 0.13 0.07 0.91 -0.01
SBP 0.10 0.99 0.07 0.04 0.16 0.68 0.03 0.09 0.11 0.94 0.07 0.07
DBP -0.04 0.75 0.02 0.02 -0.05 0.99 0.04 0.05 -0.01 0.76 0.04 0.04
SS Loadings 1.95 1.57 1.18 1.10 2.22 1.50 1.02 0.99 1.99 1.51 1.05 1.03
Cumulative 
Variance (%)
19.5 35.1 47 57.9 22.2 37.2 47.4 57.3 19.9 35.1 45.5 55.8
Rotation 
"Varimax"
HyperGEN
African Americans Whites
Factors/
Variables
Factor 1 Factor 2 Factor 3 Factor 4 Factor 1 Factor 2 Factor 3 Factor 4
BMI 0.97 0.04 0.24 0.09 0.95 0.06 0.17 0.14
WAIST 0.83 0.03 0.25 0.44 0.83 0.02 0.15 0.51
WHR 0.32 0.05 0.31 0.81 0.32 0.05 0.21 0.75
INS 0.35 -0.02 0.56 0.17 0.42 0.11 0.47 0.15
GLUC -0.15 -0.02 -0.45 -0.13 -0.25 -0.07 -0.27 -0.13
LDL 0.07 0.00 0.21 0.01 0.03 0.06 0.02 0.06
HDL -0.06 0.07 -0.06 -0.08 -0.08 0.05 -0.68 -0.05
TG 0.02 0.02 0.64 0.12 0.09 0.07 0.61 0.13
SBP 0.13 0.99 0.03 0.02 0.11 0.85 0.06 0.04
DBP -0.06 0.76 -0.06 0.02 -0.04 0.80 -0.02 0.05
SS Loadings 1.90 1.56 1.54 0.93 1.97 1.40 1.23 0.90
Cumulative 
Variance (%)
19.0 34.6 50.1 59.3 19.7 33.7 45.9 54.9
Rotation 
"Varimax"
SAPPHIRe
Chinese Japanese
Factors / 
Variables
Factor 1 Factor 2 Factor 3 Factor 4 Factor 1 Factor 2 Factor 3 Factor 4
BMI 0.48 0.48 0.08 0.58 0.94 0.06 0.25 0.24
WAIST 0.80 0.38 0.08 0.35 0.66 -0.01 0.17 0.73
WHR 0.93 0.18 0.11 -0.29 0.12 0.00 0.13 0.71
INS 0.25 0.69 0.01 0.15 0.49 0.11 0.48 0.25
GLUC -0.07 -0.47 0.00 0.00 -0.20 0.03 -0.47 -0.08Page 7 of 13
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HDL -0.08 -0.46 0.01 0.03 -0.10 -0.09 -0.65 -0.09
TG 0.12 0.60 0.12 -0.07 0.05 0.12 0.54 0.10
SBP 0.09 0.03 0.90 0.11 0.10 0.70 0.16 0.01
DBP 0.05 0.05 0.92 0.10 -0.05 0.99 0.00 0.04
SS Loadings 1.85 1.68 1.68 0.60 1.64 1.53 1.32 1.20
Cumulative 
Variance (%)
18.5 35.3 52.0 58.0 16.4 31.6 44.8 56.8
†The loadings > = 0.40 are in bold.
Percent of Participants by Network and Ethnicity that Pass Thresholds per Each Risk Factor as Defined by NCEP and Percent of Participants that had 3, 4, and 5 MetS Risk Factor Combinations Beyond the NCEP ThresholdsFigu e 1
Percent of Participants by Network and Ethnicity that Pass Thresholds per Each Risk Factor as Defined by NCEP and Percent 
of Participants that had 3, 4, and 5 MetS Risk Factor Combinations Beyond the NCEP Thresholds. Footnote. MS3, MS4 and 
MS5: three, four and five risk factors beyond the NCEP thresholds; AACo-African Americans combined; AAG-Genoa African 
Americans; AAH-HyperGEN African Americans; WCo-Whites combined; WG-GENOA Whites; WH-HyperGEN Whites; 
ACo-Asians combined; AC-Chinese Asians; AJ-Japanese Asians; His-Hispanics
Table 7: Loadings of the Original Risk Factors in the Latent Factors by Network, Ethnicity (Varimax Rotation) (Continued)Page 8 of 13
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having T2D were 10.8 higher (8.3 – 14.1 a 95% odds CI)
in GENOA African Americans if participants had c-MetS.
The odds of having T2D when having c-MetS for Chinese
and Japanese were about 5 with 95% odds CI (3.1 – 11.0)
and (2.8 – 8.8), respectively.
VHA
The highest prevalence of VHA events was 17% in Hispan-
ics, followed by the HyperGEN Whites with 15%; the low-
est prevalence was 4% in the Chinese. The rest of the
groups had intermediate VHA prevalence: GENOA Afri-
can Americans, 10%; GENOA Whites, 10%; HyperGEN
African Americans 13%; and Japanese 7%.
q-MetS
Table 5 presents correlation matrices and sample sizes for
10 risk variables for MetS. Each upper or lower triangle of
a matrix corresponds to correlation coefficients and the
associated significance levels for a specified network and
ethnicity. All networks and ethnicities studied showed a
high correlation of BMI with WAIST (from 0.78 in the
Chinese to 0.9 in the GENOA Whites and the HyperGEN
African Americans), and a lower correlation of BMI with
WHR (from 0.31 in the SAPPHIRe Japanese to 0.51 in the
GENOA Whites). INS was correlated with BMI, WAIST,
GLUC, and TG, but displayed significantly lower correla-
tion with WHR. As expected TG was negatively correlated
with HDL. SBP and DBP were highly correlated to each
other (from 0.68 in the GENOA Whites to 0.84 in the
SAPPHIRe Japanese). These patterns of correlations were
likely to shape the latent factors created by analyzing the
10 MetS risk variables investigated.
q-MetS with no Rotation
Tables 6 and 7 illustrate how groups of the original risk
variables contribute (load) on latent factors from FA with
and without Varimax rotation. The sums of squares of
loadings (SS Loadings) correspond to the proportion of
the variance of the original variables explained by each
latent factor identified. When no rotation was performed
on the factors, the main factor of African Americans was
composed of BMI, INS, SBP, DBP, WAIST, and WHR. In
GENOA Hispanics and Whites, BMI, INS, WAIST, and
WHR contributed in the first factor. For the Chinese, the
first factor loaded only obesity and explained 19% of the
original variance; the third factor loaded primarily obes-
ity, INS, and negative SBP and DBP, and explained about
Frequency of Subjects by Network Within Ethnicity Given MetS and T2D Affection Statusigur  2
Frequency of Subjects by Network Within Ethnicity Given MetS and T2D Affection Status.Page 9 of 13
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nents loaded in general on a separate factor with the
exception of African Americans where the loading tended
to be on the first factor. Lipids also contributed on a sep-
arate factor.
q-MetS with Varimax Rotation
After performing the Varimax rotation, Factor 1 in the
GENOA African Americans explained about 20% of the
variance in the original 10 risk variables. Four factors
explained from 55% of the variance in the original risk
variables in the HyperGEN Whites to 60% in the Hyper-
GEN African Americans. The four factors identified were
not identical among the ethnicities in each network. Fac-
tor 1 loaded essentially BMI, WAIST, and INS in African
Americans, Hispanics, Whites, and Japanese, but less BMI
and INS compared to WAIST and WHR in Chinese. SBP
and DBP contributed in a separate factor for each network
and ethnicity. TG, HDL, INS, and GLUC contributed in a
separate latent factor. The remaining fourth factors loaded
WAIST and WHR in most of the networks' ethnicities, but
in the Chinese loaded BMI and WAIST, with negative
loading for WHR.
Discussion
One of the major contributors to MetS, as can be seen in
Figure 1, was high BP. About 70% of African Americans,
Whites, or Asians, and 58% of Hispanics sampled had BP
above the NCEP threshold or used anti-HT medications.
These findings coincided with the main ascertainment in
the sampled populations, reflecting the main goal of
FBPP, to study the genetic causes of high blood pressure.
The ascertainment schemes within each network may
have played a role in the observed associations of the fea-
tures of MetS and the prevalence of c-MetS. However, the
characteristics described in the results stress that there are
important ethnic differences, which need to be taken into
consideration when evaluating / diagnosing MetS.
If we compare the prevalence of MetS in our study and a
23–24% of U.S. MetS prevalence reported by Ford et al.
(2004) using data from the National Health and Nutri-
tion Examination Survey (NHANES), it is evident that our
US samples have a higher prevalence of MetS than the
general US population [16]. In our study of 3,867 African
Americans, 3,466 Whites, 2,211 Asians and 1,799 Hispan-
ics, 37%, 46%, 21%, and 73%, respectively, were classi-
fied with c-MetS. This trend emphasizes the fact that
selection for hypertension in most cases was associated
with higher prevalence of MetS. Another example empha-
sizing that selection for a disorder part of the MetS,
increases the prevalence of MetS, comes from a multina-
tional study, Genetic Epidemiology of Metabolic Syn-
drome Project. This study has revealed a prevalence of
76% of MetS out of 1,436 participants, as result of select-
ing for atherogenic dyslipidemia [17].
The prevalence of MetS was comparable across Networks
within the same ethnicity. However, there are ethnic
differences in the prevalence of MetS. Prevalence of c-
MetS is high in GENOA Hispanics (Figure 1). They also
show high association of c-MetS with T2D (Figure 2).
Although we believe that the prevalence of MetS is influ-
enced by selection for type 2 diabetes, these results are in
accordance with a large body of literature that illustrates
that Hispanics have a trend for being more susceptible to
MetS. Simon et al (2003) have reported that the preva-
lence of T2D was approximately two times higher among
Hispanics than non-Hispanics [18]. McNeely and Boyko
(2004) have reported that odds ratios for diabetes, com-
pared to Whites, were 1 for Asians, 2.3 for African Ameri-
cans, 2 for Hispanics, 2.2 for Native Americans, and 3.1
for Pacific Islanders [19]. Sanchez-Castillo et al. (2004)
reported that in excess of 50% of adult population in Mex-
ico are overweight and obese [20]. Furthermore, in our
data, we found that the VHA events were highest in His-
panics. Our findings are in accord with the literature
reporting that Mexican Americans had a 70% greater risk
of cardiovascular mortality, and a 60% greater risk of cor-
onary heart disease mortality than non-Hispanic Whites
[21]. A higher incidence of hospitalized myocardial inf-
Table 4: Association Between MetS and T2D in Networks Within Ethnicity
Odds Ratio Prevalence Ratio
Network: Ethnicity (95% Confidence Interval) (95% Confidence Interval)
GENOA: African Americans 10.8 (8.3 – 14.1) 6.2 (4.9 – 7.8)
GENOA: Hispanics 7.3 (5.8 – 9.2) 2.5 (2.2 – 2.8)
GENOA: Whites 8.0 (5.3 – 12.2) 6.5 (4.4 – 9.6)
HyperGEN: African Americans 9.7 (7.6 – 12.4) 5.7 (4.6 – 5.9)
HyperGEN: Whites 6.7 (4.9 – 9.1) 5.1 (3.9 – 6.8)
SAPPHIRe: Chinese 5.8 (3.1 – 11.0) 5.4 (2.9 – 9.9)
SAPPHIRe: Japanese 5.0 (2.8 – 8.8) 4.0 (2.4 – 6.6)Page 10 of 13
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was also reported [22].
Conversely, Asians (and especially the Chinese) are leaner
than others. We recognize that SAPPHIRe exclusion crite-
ria biased the obesity findings. They also had lower T2D
prevalence (Figure 2), because specifically the treated type
2 diabetics were excluded earlier than the clinical visit.
They had lower prevalence of c-MetS. It is suggested that
the NCEP criteria for obesity may not be suitable for the
Japanese [23]. Tan et al. (2004) suggested that the NCEP
definition of MetS underestimates its prevalence in Asian
populations, because it embodies an unsuitable threshold
of central obesity for Asians [24]. For example, in the
FBPP Chinese sample (which represented individuals of
Chinese origin living in Taiwan), if one would have low-
ered the threshold for WAIST as Tan et al. (2004) sug-
gested, the prevalence of c-MetS in them would have
increased.
Among African Americans and Hispanics, men had signif-
icantly lower odds of having c-MetS than women (Results
not shown). Other authors have concluded that African-
American women and Hispanic men and women have the
highest prevalence of MetS. They attributed this to higher
BP, obesity, and diabetes in African Americans, and the
high prevalence of obesity and diabetes in Hispanics [25].
In the FBPP, more Whites had TG and HDL beyond the
NCEP threshold as compared to African Americans.
In our study, each of the ethnicities considered showed
significant MetS and T2D associations. Young et al.
(2003), in a longitudinal cohort study of 429,918 veter-
ans with diabetes, found that African Americans and
Native Americans had a higher odds ratio (1.3 and 1.5
respectively) for having early diabetic nephropathy than
Whites [26]. In the FBPP, the Hispanic sample exhibits a
high occurrence of MetS along with T2D (57%) in associ-
ation with a constellation of several risk factors for MetS
beyond the NCEP thresholds. Our data (Figure 2), dem-
onstrate also a small group of subjects with T2D, not clas-
sified as having MetS. This group is intriguing, because
three or more risk factors are under the NCEP threshold,
and it represents a deviation from the general notion that
a cluster of risk factors of MetS may lead to T2D develop-
ment. Is it possible that the scale for classifying T2D is
error prone? Is there any genetic factor in this group that
affects GLUC levels in the blood, without interfering with
obesity and dyslipidemia pathways? A genetic analysis of
this group in contrast with one having concurrently MetS
and T2D, may identify important genetic differences
related to MetS.
Four independent factors were identified when factor
analysis was performed with Varimax rotation. Their pat-
tern was very similar in African Americans, Hispanics,
Whites, and Japanese, but not entirely so in Chinese. BMI,
WAIST, and INS contributed together mainly in a factor
labeled by us as "Obesity-INS." SBP and DBP contributed
in a separate "BP" factor. A "Lipids-INS" factor was con-
structed mainly from contributions of LDL, HDL, TG, and
INS. The last, "Central obesity" factor, was mostly an
involvement of WAIST and WHR. These 4 factors were
persistent also by gender in the HyperGEN data [14].
When no rotation was employed, the main MetS factor
represented primarily a contribution of obesity together
with INS in Hispanics, Whites, and Japanese; obesity and
BP in African Americans; and obesity in Chinese. These
patterns are quite important for a geneticist, because they
show possible underlying trait combinations. The known
interactions among traits grant ways to investigate the
underlying genes, proteins and their substructures
involved in these communications. For a clinician, the
traits groupings shed light on the most important factors
to be tackled when combating MetS. For the pharmaco-
logical research, these patterns can help in envisioning
new medications intended to tackle the excess expression
of risk variables in one, two, and/or three factors at once.
In general, our results about the structure of the factors,
which reflect multivariate correlations of the variables
studied, are supported by the literature. However, there
are also differences that could be the result of variations in
recruitment. In a study of Japanese Americans, it was
found that visceral fat was a significant correlate of hyper-
tension and independent of fasting INS [27]. In contrast,
we found that correlations of WAIST/WHR with INS were
highly significant in the Japanese, but not correlated with
BP components.
In conclusion, patterns of the MetS were relatively similar
across networks within ethnicity, but were statistically dif-
ferent among ethnicities. Overall, obesity was the most
prominent compound risk factor expressed in both c-
MetS and q-MetS. However, the degree of consistency in
factor structures observed across ethnicities and networks
is remarkable given that there are considerable differences
in the Network-specific study designs. The notable
exception of Hispanics in GENOA is quite understandable
since the sample was also enriched for T2D. Thus, some of
the differences especially in the prevalence of MetS are, at
least in part, attributable to the study design differences.
Nevertheless, the increase of MetS prevalence in our U.S.
samples compared to the U.S. general population con-
firmed that there is an important link between HT and
MetS. Together, our results underline that MetS is a com-
pound phenotype, where obesity, dyslipidemia, and
hypertension enable MetS. If we assume that obesity and
dyslipidemia have separate biochemical pathways for
their expression, it appears that the presence of INS inPage 11 of 13
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that INS is an important contributor and possibly a con-
nector of pathways in the development of MetS.
The reported findings will be useful if they lead to innova-
tions. One application of these results can be the genetic
analysis of the new MetS created data. It is well known
that a categorical trait has less power in detecting genetic
linkage as compared to a quantitative trait for a complex
phenotype. Two types of q-MetS factor scores (with and
without Varimax rotation) provide ample opportunity to
discover quantitative trait loci for MetS. Parallel with this
work, we have undertaken a detailed genetic analysis of
the MetS factors that will be reflected in another
publication (unpublished observations). Qualitative and
quantitative characterization of MetS in the rich Family
Blood Pressure Program pooled data will help in getting a
better understanding of the genetic inheritance underly-
ing MetS and its interaction with the environmental
causes.
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